Taika Capital’s GSK GSK Stock Holding History

Taika Capital’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-25,150	Closed	-$1.03M	–	89
2024 Q3	$1.03M	Buy	+25,150	New	+$1.03M	0.77%	30
2023 Q1	–	Sell	-63,200	Closed	-$2.22M	–	49
2022 Q4	$2.22M	Buy	+63,200	New	+$2.11M	1.17%	32

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Taika Capital's GSK Position: Q4 2024 in Review

Taika Capital sold out of GSK (GSK) in Q4 2024, closing a stake of 25,150 shares — an estimated $1.03M sold.

Taika Capital first reported a position in GSK in Q4 2022 and held it in 2 quarters. The position peaked at $2.22M in Q4 2022. 849 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

Taika Capital reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
Taika Capital sold 25,150 GSK shares in Q4 2024, an estimated $1.03M.
Taika Capital first reported a position in GSK in Q4 2022 and held it in 2 quarters.
Taika Capital's GSK position peaked at $2.22M in Q4 2022.
849 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on Taika Capital's 13F filing for Q4 2024, filed 7 Feb 2025.